156 related articles for article (PubMed ID: 36878845)
1. Cancer-associated fibroblasts suppressed ferroptosis in glioblastoma via upregulating lncRNA DLEU1.
Zhao J; Yang S; Lv C; Liu Y
Am J Physiol Cell Physiol; 2023 May; 324(5):C1039-C1052. PubMed ID: 36878845
[TBL] [Abstract][Full Text] [Related]
2. Long non‑coding RNA DLEU1 promotes cell proliferation of glioblastoma multiforme.
Wang J; Quan X; Peng D; Hu G
Mol Med Rep; 2019 Aug; 20(2):1873-1882. PubMed ID: 31257517
[TBL] [Abstract][Full Text] [Related]
3. SP1-DLEU1-miR-4429 feedback loop promotes cell proliferative and anti-apoptotic abilities in human glioblastoma.
Liu X; Chen R; Liu L
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31713587
[TBL] [Abstract][Full Text] [Related]
4. Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma.
Zhang Z; Yin J; Lu C; Wei Y; Zeng A; You Y
J Exp Clin Cancer Res; 2019 Apr; 38(1):166. PubMed ID: 30992025
[TBL] [Abstract][Full Text] [Related]
5. Epigenetically silenced lncRNA SNAI3-AS1 promotes ferroptosis in glioma via perturbing the m
Zheng J; Zhang Q; Zhao Z; Qiu Y; Zhou Y; Wu Z; Jiang C; Wang X; Jiang X
J Exp Clin Cancer Res; 2023 May; 42(1):127. PubMed ID: 37202791
[TBL] [Abstract][Full Text] [Related]
6. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma.
Lu C; Wei Y; Wang X; Zhang Z; Yin J; Li W; Chen L; Lyu X; Shi Z; Yan W; You Y
Mol Cancer; 2020 Feb; 19(1):28. PubMed ID: 32039732
[TBL] [Abstract][Full Text] [Related]
7. miR-491-5p regulates the susceptibility of glioblastoma to ferroptosis through TP53.
Jie XF; Li YP; Liu S; Fu Y; Xiong YY
Biochem Biophys Res Commun; 2023 Sep; 671():309-317. PubMed ID: 37327702
[TBL] [Abstract][Full Text] [Related]
8. LncRNA HOXA-AS3 promotes the malignancy of glioblastoma through regulating miR-455-5p/USP3 axis.
Chen W; Li Q; Zhang G; Wang H; Zhu Z; Chen L
J Cell Mol Med; 2020 Oct; 24(20):11755-11767. PubMed ID: 32918360
[TBL] [Abstract][Full Text] [Related]
9. PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition.
Gao Z; Xu J; Fan Y; Qi Y; Wang S; Zhao S; Guo X; Xue H; Deng L; Zhao R; Sun C; Zhang P; Li G
J Exp Clin Cancer Res; 2022 Jul; 41(1):223. PubMed ID: 35836243
[TBL] [Abstract][Full Text] [Related]
10. DLEU1 contributes to ovarian carcinoma tumourigenesis and development by interacting with miR-490-3p and altering CDK1 expression.
Wang LL; Sun KX; Wu DD; Xiu YL; Chen X; Chen S; Zong ZH; Sang XB; Liu Y; Zhao Y
J Cell Mol Med; 2017 Nov; 21(11):3055-3065. PubMed ID: 28598010
[TBL] [Abstract][Full Text] [Related]
11. LncRNA DLEU1/microRNA-300/RAB22A axis regulates migration and invasion of breast cancer cells.
Wang C; Xie XX; Li WJ; Jiang DQ
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10410-10421. PubMed ID: 31841195
[TBL] [Abstract][Full Text] [Related]
12. Silencing lncRNA SLC16A1-AS1 Induced Ferroptosis in Renal Cell Carcinoma Through miR-143-3p/SLC7A11 Signaling.
Li YZ; Zhu HC; Du Y; Zhao HC; Wang L
Technol Cancer Res Treat; 2022; 21():15330338221077803. PubMed ID: 35167383
[No Abstract] [Full Text] [Related]
13. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.
Wu W; Yu T; Wu Y; Tian W; Zhang J; Wang Y
J Exp Clin Cancer Res; 2019 Mar; 38(1):133. PubMed ID: 30898167
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA DLEU1 aggravates pancreatic ductal adenocarcinoma carcinogenesis via the miR-381/CXCR4 axis.
Gao S; Cai Y; Zhang H; Hu F; Hou L; Xu Q
J Cell Physiol; 2019 May; 234(5):6746-6757. PubMed ID: 30382579
[TBL] [Abstract][Full Text] [Related]
15. The transcript ENST00000444125 of lncRNA LINC01503 promotes cancer stem cell properties of glioblastoma cells via reducing FBXW1 mediated GLI2 degradation.
Wei P; Jiang J; Xiao M; Zeng M; Liu X; Zhao B; Chen F
Exp Cell Res; 2022 Mar; 412(1):113009. PubMed ID: 34990616
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of lncRNA DLEU1 inhibits the tumorigenesis of oral squamous cell carcinoma via regulation of miR‑149‑5p/CDK6 axis.
Lv T; Liu H; Wu Y; Huang W
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880596
[TBL] [Abstract][Full Text] [Related]
17. CircLRFN5 inhibits the progression of glioblastoma via PRRX2/GCH1 mediated ferroptosis.
Jiang Y; Zhao J; Li R; Liu Y; Zhou L; Wang C; Lv C; Gao L; Cui D
J Exp Clin Cancer Res; 2022 Oct; 41(1):307. PubMed ID: 36266731
[TBL] [Abstract][Full Text] [Related]
18. Silencing of lncRNA DLEU1 inhibits tumorigenesis of ovarian cancer via regulating miR-429/TFAP2A axis.
Xu H; Wang L; Jiang X
Mol Cell Biochem; 2021 Feb; 476(2):1051-1061. PubMed ID: 33170430
[TBL] [Abstract][Full Text] [Related]
19. YY1-induced DLEU1/miR-149-5p Promotes Malignant Biological Behavior of Cholangiocarcinoma through Upregulating YAP1/TEAD2/SOX2.
Li J; Jiang X; Xu Y; Kang P; Huang P; Meng N; Wang H; Zheng W; Wang H; Wang Z; Zhong X; Cui Y
Int J Biol Sci; 2022; 18(11):4301-4315. PubMed ID: 35864972
[TBL] [Abstract][Full Text] [Related]
20. CAF-derived midkine promotes EMT and cisplatin resistance by upregulating lncRNA ST7-AS1 in gastric cancer.
Yang KD; Wang Y; Zhang F; Li QL; Luo BH; Feng DY; Zeng ZJ
Mol Cell Biochem; 2022 Nov; 477(11):2493-2505. PubMed ID: 35588343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
